- Home
- KG vs TMDX Comparison
KG vs TMDX Comparison
Compare KG & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KG
- TMDX
- Stock Information
- Founded
- KG N/A
- TMDX 1998
- Country
- KG Bermuda
- TMDX United States
- Employees
- KG N/A
- TMDX N/A
- Industry
- KG Property-Casualty Insurers
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- KG Finance
- TMDX Health Care
- Exchange
- KG Nasdaq
- TMDX Nasdaq
- Market Cap
- KG 2.5B
- TMDX 4.8B
- IPO Year
- KG N/A
- TMDX 2019
- Fundamental
- Price
- KG $25.79
- TMDX $128.97
- Analyst Decision
- KG
- TMDX Buy
- Analyst Count
- KG 0
- TMDX 10
- Target Price
- KG N/A
- TMDX $127.33
- AVG Volume (30 Days)
- KG 44.8K
- TMDX 838.7K
- Earning Date
- KG 08-15-2025
- TMDX 07-30-2025
- Dividend Yield
- KG N/A
- TMDX N/A
- EPS Growth
- KG N/A
- TMDX N/A
- EPS
- KG N/A
- TMDX 1.41
- Revenue
- KG $5,462,137.00
- TMDX $488,227,000.00
- Revenue This Year
- KG N/A
- TMDX $34.07
- Revenue Next Year
- KG N/A
- TMDX $20.76
- P/E Ratio
- KG $607.37
- TMDX $92.35
- Revenue Growth
- KG 250.18
- TMDX 64.43
- 52 Week Low
- KG $20.51
- TMDX $55.00
- 52 Week High
- KG $36.80
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- KG N/A
- TMDX 59.35
- Support Level
- KG N/A
- TMDX $120.36
- Resistance Level
- KG N/A
- TMDX $133.49
- Average True Range (ATR)
- KG 0.00
- TMDX 5.58
- MACD
- KG 0.00
- TMDX -1.35
- Stochastic Oscillator
- KG 0.00
- TMDX 60.26
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.